Thomas Andrew Rowland - 28 Mar 2024 Form 3 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP, HEAD - ESTABLISHED BRANDS
Signature
/s/ Thomas Rowland, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
28 Mar 2024
Net transactions value
$0
Form type
3
Filing time
08 Apr 2024, 21:53:12 UTC
Next filing
18 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ANIP Common Stock 34,036 28 Mar 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount includes restricted stock awards, 4,553 of which have vested and 19,223 of which are currently unvested, which will vest in four equal annual installments on the first, second, third, and fourth anniversaries of the applicable grant dates for each award.
F2 Amount also includes 10,260 performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. The performance stock units are presented at their maximum potential vesting of 200%.

Remarks:

Exhibit 24 - Power of Attorney